Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer, World Health Organization, 150 cours Albert Thomas, 69372 Lyon CEDEX 08, France.
Centre of Excellence for Nutrition, North-West University, Potchefstroom, South Africa.
BMJ. 2018 May 29;361:k934. doi: 10.1136/bmj.k934.
To investigate the association between alcohol consumption (at baseline and over lifetime) and non-fatal and fatal coronary heart disease (CHD) and stroke.
Multicentre case-cohort study.
A study of cardiovascular disease (CVD) determinants within the European Prospective Investigation into Cancer and nutrition cohort (EPIC-CVD) from eight European countries.
32 549 participants without baseline CVD, comprised of incident CVD cases and a subcohort for comparison.
Non-fatal and fatal CHD and stroke (including ischaemic and haemorrhagic stroke).
There were 9307 non-fatal CHD events, 1699 fatal CHD, 5855 non-fatal stroke, and 733 fatal stroke. Baseline alcohol intake was inversely associated with non-fatal CHD, with a hazard ratio of 0.94 (95% confidence interval 0.92 to 0.96) per 12 g/day higher intake. There was a J shaped association between baseline alcohol intake and risk of fatal CHD. The hazard ratios were 0.83 (0.70 to 0.98), 0.65 (0.53 to 0.81), and 0.82 (0.65 to 1.03) for categories 5.0-14.9 g/day, 15.0-29.9 g/day, and 30.0-59.9 g/day of total alcohol intake, respectively, compared with 0.1-4.9 g/day. In contrast, hazard ratios for non-fatal and fatal stroke risk were 1.04 (1.02 to 1.07), and 1.05 (0.98 to 1.13) per 12 g/day increase in baseline alcohol intake, respectively, including broadly similar findings for ischaemic and haemorrhagic stroke. Associations with cardiovascular outcomes were broadly similar with average lifetime alcohol consumption as for baseline alcohol intake, and across the eight countries studied. There was no strong evidence for interactions of alcohol consumption with smoking status on the risk of CVD events.
Alcohol intake was inversely associated with non-fatal CHD risk but positively associated with the risk of different stroke subtypes. This highlights the opposing associations of alcohol intake with different CVD types and strengthens the evidence for policies to reduce alcohol consumption.
探讨饮酒(基线时和终生)与非致死性和致死性冠心病(CHD)和卒中的相关性。
多中心病例对照研究。
来自欧洲癌症与营养前瞻性调查(EPIC)中 8 个欧洲国家的心血管疾病(CVD)决定因素研究(EPIC-CVD)。
32549 名无基线 CVD 的参与者,包括新发 CVD 病例和一个亚组用于比较。
非致死性和致死性 CHD 和卒中(包括缺血性和出血性卒中)。
共发生 9307 例非致死性 CHD 事件、1699 例致死性 CHD、5855 例非致死性卒中及 733 例致死性卒中。基线时饮酒与非致死性 CHD 呈负相关,每增加 12 g/天,风险比为 0.94(95%置信区间 0.92 至 0.96)。基线饮酒与致死性 CHD 风险之间呈 J 形关联。摄入量类别分别为 5.0-14.9 g/天、15.0-29.9 g/天和 30.0-59.9 g/天的风险比为 0.83(0.70 至 0.98)、0.65(0.53 至 0.81)和 0.82(0.65 至 1.03),与 0.1-4.9 g/天相比。相比之下,非致死性和致死性卒中风险的风险比分别为 1.04(1.02 至 1.07)和 1.05(0.98 至 1.13),每增加 12 g/天的基线饮酒量,包括缺血性和出血性卒中的发现基本相似。心血管结局的相关性与基线饮酒量时的平均终生饮酒量基本相似,且在研究的 8 个国家中也基本相似。没有强有力的证据表明饮酒与吸烟状况之间存在交互作用,会影响 CVD 事件的风险。
饮酒与非致死性 CHD 风险呈负相关,但与不同卒中亚型的风险呈正相关。这突显了饮酒与不同 CVD 类型的相反相关性,并加强了减少饮酒量的政策的证据。